Definition of Mabthera. Meaning of Mabthera. Synonyms of Mabthera

Here you will find one or more explanations in English for the word Mabthera. Also in the bottom left of the page several parts of wikipedia pages related to the word Mabthera and, of course, Mabthera synonyms and on the right images related to the word Mabthera.

Definition of Mabthera

No result for Mabthera. Showing similar results...

Meaning of Mabthera from wikipedia

- Rituximab in combination with hyaluronidase human, sold under the brand names Mabthera SC and Rituxan Hycela, is used to treat follicular lymphoma, diffuse large...
- Emcure for manufacturing its blockbuster anticancer drugs Herceptin and Mabthera in India. Under this programme the cancer drugs shall be made available...
- (AMD). Luxturna (voretigene neparvovec), for Leber's congenital amaurosis. MabThera (rituximab), for B-cell chronic lymphocytic leukaemia (and other haematological...
- ANCA-****ociated Vasculitis Chronic lymphocytic leukemia 1997 2006 2011 1998 (as MabThera) The first monoclonal antibody for cancer developed by IDEC, prior to merging...
- In combination with anti-CD20 monoclonal antibody rituximab (Rituxan, Mabthera) it is called R-DHAP or DHAP-R. [R]-DHAP regimen consists of: Rituximab...
- (Simulect), cetuximab (Erbitux), infliximab (Remicade) and rituximab (MabThera). There are also several examples of chimerics currently in clinical trials...
- cancer Avastin 6847 6686 10 rituximab non-Hodgkin's lymphoma Rituxan, MabThera 6750 7298 11 rivaroxaban anticoagulant Xarelto 6589 6234 12 aflibercept...
- Crohn's disease, psoriasis, psoriatic arthritis, and asthma Rituximab MabThera, Rituxan mab chimeric CD20 Y lymphomas, leukemias, some autoimmune disorders...
- B-cell lymphoma (PMBCL), stomach cancer, cervical cancer Rituximab Rituxan, Mabthera chimeric CD20 1997 non-Hodgkin lymphoma Rituximab/hyaluronidase Rituxan...
- rituximab monoclonal antibody, sold under the trade name Rituxan (or as Mabthera in Europe and Australia). Rituximab may have good activity against MCL...